|
|
Evaluation of serum alkaline phosphataseon heart disease in maintenance hemodialysis patients |
SHAN Jing1, GENG Yanqiu2, LIU Dong1, GAO Zhuo1 |
1. Department of Nephrology, Air Force Medical Center, PLA, Beijing 100142, China; 2. Department of Nephrology, the Third Medical Center of PLA General Hospital, Beijing 100039, China |
|
|
Abstract Objective To study the value of serum alkaline phosphatase(ALP) in the assessment of heart disease among maintenance hemodialysis patients. Methods The clinical data on 98 patients who received regular hemodialysis treatment in Air Force Medical Center between January 2017 and October 2019 was retrospectively analyzed. According to ALP levels, the patients were divided into the elevated ALP group (>120 U/L) and normal ALP group (≤120 U/L), with 49 patients in each. Meanwhile, levels of serum albumin (ALB), hemoglobin (HB), high density lipoprotein (HDL), low density lipoprotein (LDL), triglyceride (TG), total cholesterol (TC), C-reactive protein (CRP), blood calcium (CA), blood phosphorus (P), intact parathyroid hormone (iPTH) and other indicators were tested. The cardiac color Doppler ultrasound was used and the carotid artery intima-media thickness was examined. The difference in the results of related auxiliary examinations between the two groups was observed, while the effects of the above test results on cardiac lesions were analyzed. Results There was no significant difference in levels of ALB, HB, HDL, LDL, TG or TC between the two groups (P>0.05). However, there was significant difference in levels of CRP, CA, P, iPTH, LVEF, maximum peak velocity of early diastolic filling/maximum peak velocity of late diastolic filling (E/A), left atrial enlargement, left ventricular enlargement, carotid plaque, cardiac valve calcification and carotid IMT between the two groups (P<0.05). Correlation analysis showed that ALP, CRP, P, Ca and carotid IMT were related to heart disease. Multivariate regression analysis indicated that ALP levels were an independent influencing factor of heart disease (P<0.05). Conclusions Levels of ALP in MHD patients are of high clinical value for assessing the severity of heart disease.
|
Received: 24 May 2021
|
|
|
|
|
[1] |
王一琳, 李声宏. 颈动脉内中膜厚度与血栓调节蛋白联合检测对血液透析患者并发心血管疾病的预测价值[J].山东医药,2019,59(1): 24-27.
|
[2] |
吴玉芳, 张春容.碱性磷酸酶与冠心病及冠状动脉病变范围的相关性[J]. 广西医学, 2020, 42(6):681-684.
|
[3] |
钟晓芬,林 琳.心脏瓣膜钙化与冠心病发病的关系分析[J].医学理论与实践,2020,33(14):2359-2360.
|
[4] |
Fowkes F G, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010:a systematic review and analysis[J].Lancet,2013,382(9901):1329-1340.
|
[5] |
陈爱群,孙 颖, 赵 班, 等. 血成纤维细胞生长因子23水平和颈动脉内中膜厚度对维持性血液透析患者长期预后的影响[J]. 中华老年医学杂志, 2019, 38(7):769-774.
|
[6] |
Ha Lahati, Shi JunBao, Yu Haiyi, et al. Association between serum cartilage oligomeric matrix protein andcoronary artery calcification in maintenance hemodialysis patients[J]. J Geriatric Cardiol, 2020,17(2):67-73.
|
[7] |
Viecelli A K, O’Lone E, Sautenet B, et al. Vascular access outcomes reported in maintenance hemodialysis trials: a systematic review[J]. Am J Kidney Dis, 2018, 71(3):382-391.
|
[8] |
Assimon M M, Brookhart M A, Fine J P, et al. A comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis[J].Am J Kidney Dis, 2018, 72 (3):337-348.
|
[9] |
段玮丽,于彤彤, 宋 佳,等. 血清碱性磷酸酶水平对急性冠状动脉综合征患者预后的影响[J].中国心血管病研究,2019, 17(6): 513-517.
|
[10] |
陈 洁, 陈 妙, 应一樱, 等. 冠状动脉钙化积分对于透析患者心血管事件发生风险的预测价值[J]. 中华全科医学, 2019, 17(11):65-68.
|
[11] |
Jamal S A,Hayden J A,Beyene J.Low bone mineral density and fractures inlong-term hemodialysis patients: a meta-analysis[J]. Am J Kidney Dis, 2007, 49 (5):674-681.
|
[12] |
Iimori S,Mori Y,Akita W,et al.Diagnostic usefulness of bone mineral densityand biochemical markers of bone turn over in predicting fracture in CKD stage 5Dpatients-a single-center cohort study[J].Nephrol Dial Transplant, 2012, 27(1):345-351.
|
[13] |
Ray L, Nanda S K, Chatterjee A, et al. A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: need for new reference ranges [J]. Int J Appl Basic Med Res, 2015, 5(1):31-35.
|
[14] |
伍金秋, 钟 清. 血清碱性磷酸酶在慢性肾脏病矿物质和骨代谢紊乱发生发展中作用的研究进展[J]. 山东医药, 2018, 58(21): 102-105.
|
[15] |
Krishnamurthy V R, Baird B C, Wei G, et al. Associations of serum alkaline phosphatase with metabolic syndrome and mortality [J]. Am J Med, 2011,124(6):561-566.
|
[16] |
Blayney M J, Pisoni R L, Bragg-Gresham J L, et al. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death [J]. Kidney Int, 2008, 74(5):655-663.
|
[17] |
Regidor D L, Kovesdy C P, Mehrotra R, et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients [J]. J Am Soc Nephrol, 2008, 19(11):2193-2203.
|
[18] |
Iqbal M P, Mehboobali N, Azam I, et al. Association of alkaline phosphatase with acute myocardial infarction in a population with high prevalence of hypovitaminosis D [J]. Clin Chimica Acta, 2013,425:192-195.
|
[19] |
刘雪姣, 谢晓东, 程 虹, 等.甲状旁腺增生在维持性血液透析患者全因死亡和主要不良心脏事件中的作用[J]. 中国血液净化, 2020, 19(9):592-597.
|
[20] |
佴志慧, 邢 智, 阿丽米拉·赛依提江, 等. 冠心病患者中丙氨酸氨基转移酶与冠状动脉粥样硬化病变程度的相关性分析[J]. 新疆医科大学学报, 2019, 42(3):288-292.
|
[21] |
魏日胞, 龙丽娟, 蔡广研, 等. 老年慢性肾衰病人颈动脉内中膜厚度的变化及其相关因素研究[J]. 解放军医学杂志, 2002, 27(5): 447-449.
|
[22] |
Salonen J T, Salonen R. Ultrasonographically assessed carotid morphology and the risk of oronary heart disease[J]. Arterioscler Thromb, 1991,11:1245.
|
[23] |
冯世栋,田秀娟,王 妍,等. 维生素 D 对终末期肾病患者心血管保护研究进展 [J]. 新医学,2018,12(49):863-867.
|
[24] |
刘俊生, 刘 莉, 杨丽娟, 等. 血清iPTH、血浆BNP、NT-proBNP水平在CKD5期患者心功能评价中的应用价值分析[J]. 中华全科医学, 2018, 16(9):1427-1430.
|
[25] |
罗湘凡, 曾 辉, 王英莉, 等.超声检测颈动脉斑块与冠状动脉狭窄发病的关联性研究[J].中国医学装备, 2019, 16(7):102-105.
|
|
|
|